重点产品
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20258 | CRT0273750 | 1979939-16-6 | ≧98.0% |  |
| CRT0273750 modulates LPA levels in plasma and is suitable for in vivo studies. | ||||
| 20376 | TOFA ( RMI14514; MDL14514) | 54857-86-2 | ≧98.0% | -2-FUROIC_ACID_54857-86-2.png) |
| TOFA (RMI14514; MDL14514) 是乙酰辅酶A 羧化酶-α (ACCA) 的变构抑制剂。在 | ||||
| 20102901 | Razuprotafib | 1008510-37-9 | ≧98.0% |  |
| Razuprotafib，也称为AKB-9778，是血管内皮蛋白酪氨酸磷酸酶（VE-PTP） | ||||
| 2105071 | AP1189 acetate | 959850-74-9 | ≧98.0% |  |
| AP1189 is a melanocortin receptor agonist on MC1 and MC3 receptors. | ||||
| 20103003 | ML380 | 1627138-52-6 | ≧98.0% |  |
| ML380 is a highly potent and the first CNS penetrant M5 positive allosteric modulator | ||||
| 2071535 | Danicopan | 1903768-17-1 | ≧98.0% |  |
| Danicopan, aslo known as ACH-4471 and ACH-0144471, is a highly potent, orally active | ||||
| 20259 | Elinzanetant ( NT-814 ) | 929046-33-3 | ≧98.0% |  |
| Elinzanetant，以前称为 NT-814 (45)，是一种双重 NK1,3R 拮抗剂，因此有 | ||||
| 20294 | Paltusotine ( CRN-00808 ) | 2172870-89-0 | ≧98.0% |  |
| Paltusotine 是一类新型的、口服、选择性、非肽类2型生长抑素受体 | ||||
| 19381 | Abrocitinib | 1622902-68-4 | >98% |  |
| Abrocitinib（PF-04965842）是Pifzer研发的是一种Janus激酶抑制剂药物，目 | ||||
| 24003 | NVL-655 ( ALK-IN-27 ) | 2739866-40-9 | ≧98.0% | .png) |
| NVL-655是一种新型脑渗透性ALK选择性抑制剂，旨在解决目前可用的 | ||||
| 61726 | Ensifentrine ( RPL554 ) | 1884461-72-6 | ≧98.0% | _1884461-72-6.png) |
| Ensifentrine (RPL554) is an investigational, first-in-class, inhaled dual inhibitor o | ||||
| 20513 | ZINC40099027 (ZN27) | 1211825-25-0 | ≧98.0% |  |
| ZINC40099027 (ZN27) 是一种特异性粘着斑激酶 (FAK) 激活剂，可促进缺血 | ||||